Mayo Clinic
Subject: RE: SRRC
Abstract
Debates criteria for funding scientific proposals. States that WSA's business is to support research that is scientifically sound, and that which supports information needs of the company based on the current regulatory/litigation environment. Opines, "grants that provide the company information should be approved only if we need the information and the design and investigators are qualified to do the work." Cites ETS examples. Argues that information needs of the company vary from one country to another, but are "dominated by US thinking." Argues that proposals not approved for funding might still be funded by outside organizations, under the administration of WSA.
Fields
- Notes
two page document is series of three e-mail letters with four separate Bates numbers imprinted
- Type
- Telex
- Letter
- Company
- Philip Morris
- Site
- MN Depository
- Author
- Sanders, Edward B. (Ted), Ph.D. (PM Dir. of Chemical Research)Neuchatel, '99
- Recipient
- Ellis, Cathy Lynn, Ph.D. (PM VP of Worldwide Scientific Affairs)Director of Research at Philip Morris U.S.A. in 1994. In 1997 was Senior VP of R&D at PM (2505370877). Osdene protégé.
- Named Organization
- National Institutes of Health
- Region
- United States
- Eastern Europe
- EU
- Eastern Europe
- Thesaurus Term
- Industry Sponsored Research
- Environmental Tobacco Smoke
- Industry Strategies
- Lawsuits
- Regulations
- Environmental Tobacco Smoke
No images found for document.